Norinchukin Bank, The Gilead Sciences, Inc. Transaction History

Norinchukin Bank, The

$4.18 Billion
Q3 2024

A detailed history of Norinchukin Bank, The transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Norinchukin Bank, The holds 62,372 shares of GILD stock, worth $5.47 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

62,372

Previous 53,945 15.62%

Holding current value

$5.47 Million

Previous $3.7 Million 41.26%

% of portfolio

0.13%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $561,153 - $707,783	8,427 Added 15.62%	62,372 $5.23 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $13,829 - $15,960	219 Added 0.41%	53,945 $3.7 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $79,954 - $97,502	-1,117 Reduced 2.04%	53,726 $3.94 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $576,708 - $654,001	-7,871 Reduced 12.55%	54,843 $4.44 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $4.64 Million - $5.06 Million	62,714 New	62,714 $4.7 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $2.19 Million - $2.5 Million	28,824 Added 29.16%	127,655 $9.84 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $156,552 - $178,362	2,025 Added 2.09%	98,831 $8.2 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $1.38 Million - $1.98 Million	-22,075 Reduced 18.57%	96,806 $8.31 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $719,659 - $822,036	12,087 Added 11.32%	118,881 $7.33 Million
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $1.34 Million - $1.51 Million	-23,264 Reduced 17.89%	106,794 $6.6 Million
Q1 2022 May 12, 2022	BUY	$57.92 - $72.58 $674,130 - $844,758	11,639 Added 9.83%	130,058 $7.73 Million
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $465,189 - $527,998	-7,170 Reduced 5.71%	118,419 $8.6 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $501,109 - $540,641	7,403 Added 6.26%	125,589 $8.77 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $88,413 - $96,604	1,393 Added 1.19%	118,186 $8.14 Million
Q1 2021 May 12, 2021	BUY	$60.0 - $68.46 $342,720 - $391,043	5,712 Added 5.14%	116,793 $7.55 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $85,484 - $97,405	-1,509 Reduced 1.34%	111,081 $6.47 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $156,864 - $197,230	2,526 Added 2.3%	112,590 $7.12 Million
Q2 2020 Aug 12, 2020	SELL	$72.34 - $84.0 $132,816 - $154,224	-1,836 Reduced 1.64%	110,064 $8.47 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $6.13 Million - $7.85 Million	-97,809 Reduced 46.64%	111,900 $8.37 Million
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $937,794 - $1.03 Million	-15,219 Reduced 6.77%	209,709 $13.6 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $240,663 - $265,650	3,850 Added 1.74%	224,928 $14.3 Million
Q2 2019 Aug 09, 2019	SELL	$61.87 - $69.38 $5.61 Million - $6.29 Million	-90,599 Reduced 29.07%	221,078 $14.9 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $271,067 - $303,666	4,335 Added 1.41%	311,677 $20.3 Million
Q4 2018 Feb 08, 2019	BUY	$60.54 - $79.0 $4.48 Million - $5.84 Million	73,940 Added 31.68%	307,342 $19.2 Million
Q3 2018 Nov 08, 2018	BUY	$71.28 - $78.92 $1.34 Million - $1.49 Million	18,868 Added 8.79%	233,402 $18 Million
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $1.73 Million - $2.02 Million	26,722 Added 14.23%	214,534 $15.2 Million
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $1.2 Million - $1.46 Million	16,478 Added 9.62%	187,812 $14.2 Million
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $520,035 - $610,447	7,309 Added 4.46%	171,334 $12.3 Million
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $11.8 Million - $14 Million	164,025	164,025 $13.3 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.

Account

Norinchukin Bank, The Gilead Sciences, Inc. Transaction History